Detailed information for compound 735861

Basic information

Technical information
  • TDR Targets ID: 735861
  • Name: 4-methyl-N-[2-[(quinolin-3-ylamino)methyl]phe nyl]benzenesulfonamide
  • MW: 403.497 | Formula: C23H21N3O2S
  • H donors: 2 H acceptors: 3 LogP: 4.56 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1ccc(cc1)S(=O)(=O)Nc1ccccc1CNc1cnc2c(c1)cccc2
  • InChi: 1S/C23H21N3O2S/c1-17-10-12-21(13-11-17)29(27,28)26-23-9-5-3-7-19(23)15-24-20-14-18-6-2-4-8-22(18)25-16-20/h2-14,16,24,26H,15H2,1H3
  • InChiKey: BRNGINUGKLFUGJ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 4-methyl-N-[2-[(3-quinolylamino)methyl]phenyl]benzenesulfonamide
  • AE-848/42278689
  • STK124519

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Plasmodium falciparum plasmepsin II Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Plasmodium falciparum plasmepsin II Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma japonicum ko:K01379 cathepsin D [EC3.4.23.5], putative Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium falciparum plasmepsin I Get druggable targets OG5_126885 All targets in OG5_126885
Toxoplasma gondii aspartyl protease ASP1 Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma japonicum Cathepsin D precursor, putative Get druggable targets OG5_126885 All targets in OG5_126885
Echinococcus multilocularis cathepsin d (lysosomal aspartyl protease) Get druggable targets OG5_126885 All targets in OG5_126885
Trichomonas vaginalis Clan AA, family A1, cathepsin D-like aspartic peptidase Get druggable targets OG5_126885 All targets in OG5_126885
Toxoplasma gondii aspartyl proteinase (eimepsin), putative Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium berghei plasmepsin IV Get druggable targets OG5_126885 All targets in OG5_126885
Theileria parva pepsinogen, putative Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium vivax aspartyl proteinase, putative Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium knowlesi aspartyl protease, putative Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma mansoni cathepsin D (A01 family) Get druggable targets OG5_126885 All targets in OG5_126885
Neospora caninum Pepsinogen A1, related Get druggable targets OG5_126885 All targets in OG5_126885
Neospora caninum Renin, related Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium yoelii hypothetical protein Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium knowlesi plasmepsin IV, putative Get druggable targets OG5_126885 All targets in OG5_126885
Cryptosporidium parvum membrane bound aspartyl proteinase with a signal peptide plus transmembrane domain Get druggable targets OG5_126885 All targets in OG5_126885
Candida albicans vacuolar aspartic proteinase precursor similar to S. cerevisiae PEP4 (YPL154C) Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium yoelii plasmepsin Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium yoelii hypothetical protein Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium vivax plasmepsin IV, putative Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma mansoni cathepsin D (A01 family) Get druggable targets OG5_126885 All targets in OG5_126885
Theileria parva cathepsin E, putative Get druggable targets OG5_126885 All targets in OG5_126885
Babesia bovis eukaryotic aspartyl protease family protein Get druggable targets OG5_126885 All targets in OG5_126885
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126885 All targets in OG5_126885
Candida albicans vacuolar aspartic proteinase precursor similar to S. cerevisiae PEP4 (YPL154C) Get druggable targets OG5_126885 All targets in OG5_126885
Echinococcus granulosus cathepsin d lysosomal aspartyl protease Get druggable targets OG5_126885 All targets in OG5_126885
Cryptosporidium hominis aspartyl protease precursor Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium falciparum plasmepsin IV Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma mansoni subfamily A1A unassigned peptidase (A01 family) Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium berghei plasmepsin VI Get druggable targets OG5_126885 All targets in OG5_126885
Loa Loa (eye worm) aspartic protease BmAsp-2 Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium falciparum plasmepsin VI Get druggable targets OG5_126885 All targets in OG5_126885

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni jumonji/arid domain-containing protein 0.0063 0.1805 0.2122
Echinococcus granulosus lysine specific demethylase 5A 0.0063 0.1805 0.1302
Mycobacterium tuberculosis Inositol-1-monophosphatase SuhB 0.0035 0.0361 0.5
Schistosoma mansoni jumonji/arid domain-containing protein 0.0063 0.1805 0.2122
Loa Loa (eye worm) inositol-1 0.0039 0.0578 0.1827
Echinococcus granulosus Transcription factor JmjC domain containing protein 0.0063 0.1805 0.1302
Toxoplasma gondii inositol(myo)-1(or 4)-monophosphatase 2, putative 0.0039 0.0578 0.1827
Plasmodium falciparum plasmepsin IV 0.0088 0.3164 1
Echinococcus multilocularis kinesin family 1 0.0218 1 1
Entamoeba histolytica myo-inositol monophosphatase, putative 0.0039 0.0578 1
Trypanosoma cruzi myo-inositol-1(or 4)-monophosphatase 1, putative 0.0039 0.0578 0.5
Echinococcus multilocularis lysine specific demethylase 5A 0.0063 0.1805 0.1302
Brugia malayi Inositol-1 0.0039 0.0578 0.3203
Schistosoma mansoni jumonji domain containing protein 0.0063 0.1805 0.2122
Trichomonas vaginalis Clan AA, family A1, cathepsin D-like aspartic peptidase 0.0088 0.3164 1
Toxoplasma gondii aspartyl proteinase (eimepsin), putative 0.0088 0.3164 1
Schistosoma mansoni inositol monophosphatase 0.0039 0.0578 0.068
Mycobacterium ulcerans extragenic suppressor protein SuhB 0.0039 0.0578 0.5
Mycobacterium leprae possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). 0.0035 0.0361 0.5
Echinococcus granulosus cathepsin d lysosomal aspartyl protease 0.0088 0.3164 0.2745
Plasmodium falciparum plasmepsin VI 0.0088 0.3164 1
Schistosoma mansoni subfamily A1A unassigned peptidase (A01 family) 0.0088 0.3164 0.3719
Plasmodium falciparum plasmepsin I 0.0088 0.3164 1
Schistosoma mansoni cathepsin D (A01 family) 0.0088 0.3164 0.3719
Toxoplasma gondii aspartyl protease ASP1 0.0088 0.3164 1
Schistosoma mansoni hypothetical protein 0.019 0.8507 1
Plasmodium vivax plasmepsin IV, putative 0.0088 0.3164 1
Wolbachia endosymbiont of Brugia malayi fructose-1,6-bisphosphatase 0.0039 0.0578 0.5
Loa Loa (eye worm) aspartic protease BmAsp-2 0.0088 0.3164 1
Trypanosoma brucei inositol-1(or 4)-monophosphatase 1, putative 0.0039 0.0578 0.5
Echinococcus multilocularis Transcription factor, JmjC domain containing protein 0.0063 0.1805 0.1302
Plasmodium falciparum plasmepsin II 0.0088 0.3164 1
Plasmodium vivax aspartyl proteinase, putative 0.0088 0.3164 1
Brugia malayi jmjC domain containing protein 0.0063 0.1805 1
Trypanosoma cruzi myo-inositol-1(or 4)-monophosphatase 1, putative 0.0039 0.0578 0.5
Echinococcus multilocularis cathepsin d (lysosomal aspartyl protease) 0.0088 0.3164 0.2745
Loa Loa (eye worm) hypothetical protein 0.0088 0.3164 1
Giardia lamblia Kinesin-5 0.0028 0 0.5
Brugia malayi jmjC domain containing protein 0.0063 0.1805 1
Schistosoma mansoni cathepsin D (A01 family) 0.0088 0.3164 0.3719
Leishmania major myo-inositol-1(or 4)-monophosphatase 1, putative 0.0039 0.0578 0.5
Schistosoma mansoni inositol monophosphatase 0.0039 0.0578 0.068
Loa Loa (eye worm) jmjC domain-containing protein 0.0063 0.1805 0.5705

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 7 uM Inhibition of recombinant Plasmodium falciparum plasmepsin 2 expressed in Escherichia coli using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate incubated for 40 mins prior to substrate addition measured after 10 mins by FRET-based fluorometric analysis ChEMBL. 23466235
Inhibition (binding) = 60.56 % Inhibition of recombinant Plasmodium falciparum plasmepsin 2 expressed in Escherichia coli using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate at 10 uM incubated for 40 mins prior to substrate addition measured after 10 mins by FRET-based fluorometric analysis ChEMBL. 23466235

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.